1465 Multiplex imaging identifies unique immunophenotypic and spatial characteristics associated with response to immune checkpoint inhibitors (ICIs) in metastatic urothelial cancer (mUC)

• Padmanee Sharma,
• Seunghee Kim-Schulze,
• Justin David,
• John-William Sidhom,
• Sacha Gnjatic,
• Guray Akturk,
• Matthew Galsky,
• Saurabh Gupta,
• Jonathan Anker,
• Sudeh Izadmehr

Affiliations

Padmanee Sharma

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Seunghee Kim-Schulze

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA

Justin David

Aff1 Laboratory of Tumor Immunology and Biology CCR, NCI, NIH USA

John-William Sidhom

Aff4 grid.21107.350000000121719311Johns Hopkins University School of Medicine Baltimore MD USA

Sacha Gnjatic

3Icahn School of Medicine at Mount Sinai, New York, NY, USA

Guray Akturk

2 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York City, USA

Matthew Galsky

7Tisch Cancer Institute At Mount Sinai Medical Center, New York, NY, USA

Saurabh Gupta

Department of Translational Medicine, Bristol Myers Squibb, Princeton, New Jersey, USA

Jonathan Anker

Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA

Sudeh Izadmehr

3Icahn School of Medicine at Mount Sinai, New York, NY, USA